BIO89-100
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BIO89-100, covering 2026-01-06 to 2026-01-06. Get the full timeline:
Most recent: Clinical Trial Update: Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH) [Phase 2]